Clene Nanomedicine, Inc.’s Post

Watch our webinar with Percheron Therapeutics Limited, featuring Managing Director and CEO Dr James Garner. The webinar will commence with a presentation, followed by a live Q&A with the audience, providing you the opportunity to ask James any questions about PER that you may have. Key Topics: - Overview of Percheron and their current focus - Duchenne muscular dystrophy - Current treatment landscape for Duchenne muscular dystrophy - The company's competitive advantage in an increasingly competitive market - The market opportunity for rare diseases such Duchenne and its commercial prospects - Clinical trial read-out and what the regulatory pathway looks like - Strategy for commercialising avicursen - Company’s cash position and runway Register now: https://hubs.la/Q02VYbpp0 #ASX #Stocks #Shares

Cough in IPF can be triggered by countless factors, making daily life exceptionally tough. At Trevi Therapeutics, we are committed to our research in chronic cough. Learn more about Trevi’s development in chronic cough: https://ow.ly/k7nV50TzELV #ChronicCough #CoughinIPF #Pulmonary Fibrosis #IdiopathicPulmonaryFibrosis

Struggling with the “Double-blinded placebo-controlled randomized controlled clinical trial for patients with Anal Intraepithelial Neoplasia (AIN),” Frantz Viral Therapeutics, a joint venture between Georgetown University Medical Center and Frantz Medical Group, faced numerous challenges while dealing with the trial phases. Moving ahead, they reached out to us with their concern over the ongoing challenges and sought help through Jeeva Clinical Trials Inc.'s eclinical solutions to accelerate their research. Learn how we accepted the challenges and, through our efficient and innovative solutions, assisted them in fulfilling their objectives from this case study: https://hubs.la/Q02gg2dj0 #RCT #clinicaltrials #AIN #healthtech #casestudy #randomizedclinicaltrial

🚀 Dive into the Blockbuster Journey of Tepezza! 🌟 Discover how Horizon Therapeutics transformed thyroid eye disease treatment with Tepezza, setting a new standard in ophthalmic care. Don't miss this valuable case study, which provides launch and market entry lessons for the biopharma industry! Watch now: https://lnkd.in/dcEfA4tw #Tepezza #HorizonTherapeutics #OphthalmicBlockbuster #RareDisease #ThyroidEyeDisease #TepezzaCaseStudy #Pharma #HealthcareInnovation

Improving autoimmune clinical trial inclusion requires creative thinking, explains Dr. Stacie Bell with Lupus Therapeutics in this webinar clip. Watch the full #SWHRtalksAutoimmune webinar online here: https://ow.ly/JWm150SGeke

The May edition of our Literature Highlights & detailed slide decks are now available on the Lupus-Forum, featuring key advancements in lupus research and therapeutics. This month includes topics such as the corticoid-sparing capabilities of belimumab and the new SLESIS-R score: https://ow.ly/13OG50S3Mou

EyeD Pharma is heading to Stockholm for BIO-Europe on November, 4 🇸🇪 Meet our team led by Romy Rizzo to discuss complex therapeutics for eye care and treatment of eye diseases like glaucoma or dry eye. Interested? Feel free to reach out to set up a meeting! See you in Stockholm 🇸🇪! #BIOEurope2024 #LongActingFormulations "

#eua #FDA #novedadesregulatorias Today, FDA approved first interchangeable biosimilars to treat certain types of osteoporosis and prevent bone events in cancer. A biosimilar is a biological product that is highly similar to, and has no clinically meaningful differences from, a biological product already approved by FDA. This means patients can expect the same safety and effectiveness from the biosimilar. An interchangeable biosimilar is a biosimilar that has met other requirements under the law and may be substituted without consulting the prescriber. Biosimilar and interchangeable biosimilar products may cost less than the brand-name medicine. To learn more, visit: https://lnkd.in/eAQ76c8K https://lnkd.in/eJBCbc9i

Many people have seen the Calm app on T.V., but what do you know about the apps that are actually FDA cleared and require a prescription? Here is a brief review of those apps cleared for use in mental health disorders. #digitalhealth #pharmacy #USCMann

In 2.5 hours: listen online to comment in real time or listen later.